# Alpha Lipoic Acid in Pediatrics on Hemodialysis

> **NCT06286098** · PHASE3 · ENROLLING_BY_INVITATION · sponsor: **Ain Shams University** · enrollment: 50 (estimated)

## Conditions studied

- Hemodialysis Complication
- Pediatric Kidney Disease
- Cardiovascular Complication

## Interventions

- **DRUG:** Alpha lipoic acid
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT06286098
- **Lead sponsor:** Ain Shams University
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** ENROLLING_BY_INVITATION
- **Start date:** 2025-02-02
- **Primary completion:** 2027-11-30
- **Final completion:** 2028-03-01
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2026-03-02

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06286098

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06286098, "Alpha Lipoic Acid in Pediatrics on Hemodialysis". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT06286098. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*